(0.24%) 5 199.92 points
(0.43%) 39 223 points
(0.11%) 16 320 points
(0.16%) $79.12
(4.34%) $2.28
(0.62%) $2 336.80
(2.75%) $28.36
(0.66%) $991.10
(-0.20%) $0.928
(-0.14%) $10.87
(-0.10%) $0.799
(0.86%) $92.52
0.45% $ 234.63
Live Chart Being Loaded With Signals
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide...
Stats | |
---|---|
Dzisiejszy wolumen | 316 568 |
Średni wolumen | 1.33M |
Kapitalizacja rynkowa | 67.81B |
EPS | $0 ( 2024-05-02 ) |
Następna data zysków | ( $3.32 ) 2024-08-01 |
Last Dividend | $0.950 ( 2024-03-07 ) |
Next Dividend | $0 ( N/A ) |
P/E | 50.24 |
ATR14 | $0.137 (0.06%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-03 | Byington Carrie L | Buy | 129 | Rights to Common Stock Under BD Deferred Compensation Plan |
2024-05-03 | Jones Christopher Ian Montague | Buy | 129 | Rights to Common Stock Under BD Deferred Compensation Plan |
2024-04-30 | Garrison Michael David | Sell | 1 715 | Common Stock |
2024-04-04 | Neal Shana Carol | Sell | 1 921 | Common Stock |
2024-03-14 | Spoerel Thomas J | Sell | 282 | Common Stock |
INSIDER POWER |
---|
68.42 |
Last 100 transactions |
Buy: 255 893 | Sell: 56 118 |
Wolumen Korelacja
Becton Dickinson and Co Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
AGQ | 0.901 |
SLV | 0.889 |
SIVR | 0.888 |
PSLV | 0.881 |
SO | 0.88 |
KMB | 0.88 |
LLY | 0.864 |
TDI | 0.855 |
NVS | 0.853 |
PG | 0.833 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Becton Dickinson and Co Korelacja - Waluta/Towar
Becton Dickinson and Co Finanse
Annual | 2023 |
Przychody: | $19.37B |
Zysk brutto: | $8.17B (42.17 %) |
EPS: | $4.97 |
FY | 2023 |
Przychody: | $19.37B |
Zysk brutto: | $8.17B (42.17 %) |
EPS: | $4.97 |
FY | 2022 |
Przychody: | $18.87B |
Zysk brutto: | $8.48B (44.92 %) |
EPS: | $5.93 |
FY | 2021 |
Przychody: | $20.25B |
Zysk brutto: | $9.43B (46.56 %) |
EPS: | $6.92 |
Financial Reports:
No articles found.
Becton Dickinson and Co Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.870 (N/A) |
$0.910 (N/A) |
$0.910 (N/A) |
$0.910 (N/A) |
$0.910 (N/A) |
$0.950 (N/A) |
$0.950 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.0213 | 1973-02-28 |
Last Dividend | $0.950 | 2024-03-07 |
Next Dividend | $0 | N/A |
Payout Date | 2024-03-29 | |
Next Payout Date | N/A | |
# dividends | 165 | -- |
Total Paid Out | $47.51 | -- |
Avg. Dividend % Per Year | 1.05% | -- |
Score | 4.83 | -- |
Div. Sustainability Score | 8.57 | |
Div.Growth Potential Score | 4.16 | |
Div. Directional Score | 6.37 | -- |
Year | Amount | Yield |
---|---|---|
1973 | $0.0213 | 0.94% |
1974 | $0 | 0.00% |
1975 | $0 | 0.00% |
1976 | $0 | 0.00% |
1977 | $0 | 0.00% |
1978 | $0 | 0.00% |
1979 | $0 | 0.00% |
1980 | $0 | 0.00% |
1981 | $0 | 0.00% |
1982 | $0 | 0.00% |
1983 | $0.0525 | 2.00% |
1984 | $0.0716 | 3.11% |
1985 | $0.0750 | 3.10% |
1986 | $0.0829 | 2.18% |
1987 | $0.0940 | 1.52% |
1988 | $0.109 | 1.74% |
1989 | $0.124 | 1.99% |
1990 | $0.134 | 1.76% |
1991 | $0.143 | 1.57% |
1992 | $0.150 | 1.85% |
1993 | $0.166 | 1.75% |
1994 | $0.187 | 2.13% |
1995 | $0.210 | 1.78% |
1996 | $0.232 | 1.25% |
1997 | $0.229 | 1.08% |
1998 | $0.295 | 1.21% |
1999 | $0.339 | 0.81% |
2000 | $0.365 | 1.43% |
2001 | $0.374 | 1.12% |
2002 | $0.384 | 1.18% |
2003 | $0.439 | 1.43% |
2004 | $0.614 | 1.53% |
2005 | $0.738 | 1.35% |
2006 | $0.869 | 1.47% |
2007 | $0.995 | 1.45% |
2008 | $1.156 | 1.37% |
2009 | $1.327 | 1.95% |
2010 | $1.493 | 1.95% |
2011 | $1.669 | 2.02% |
2012 | $1.800 | 2.48% |
2013 | $1.981 | 2.56% |
2014 | $2.18 | 2.05% |
2015 | $2.40 | 1.76% |
2016 | $2.64 | 1.83% |
2017 | $2.87 | 1.78% |
2018 | $2.95 | 1.39% |
2019 | $3.02 | 1.41% |
2020 | $3.12 | 1.17% |
2021 | $3.28 | 1.34% |
2022 | $3.50 | 1.42% |
2023 | $3.68 | 1.44% |
2024 | $0.950 | 0.39% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
LOMA | Dividend Knight | 2023-06-30 | Quarterly | 2 | 5.23% | 8.53 |
ORC | Dividend Royal | 2023-11-29 | Monthly | 12 | 9.23% | 8.50 |
VGI | Dividend Royal | 2024-02-09 | Monthly | 13 | 7.36% | 8.50 |
NCZ | Dividend Royal | 2024-02-09 | Monthly | 22 | 7.79% | 8.50 |
JQC | Dividend Royal | 2023-11-14 | Monthly | 22 | 6.56% | 8.50 |
ZTR | Dividend King | 2024-02-09 | Monthly | 37 | 8.35% | 8.50 |
PHK | Dividend Royal | 2023-11-10 | Monthly | 22 | 6.88% | 8.50 |
PCF | Dividend King | 2023-12-18 | Monthly | 38 | 7.05% | 8.50 |
SRV | Dividend Royal | 2023-12-04 | Monthly | 18 | 7.53% | 8.50 |
PVL | Dividend King | 2023-11-15 | Monthly | 14 | 9.37% | 8.50 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0676 | 1.500 | 8.65 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0246 | 1.200 | 9.18 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0519 | 1.500 | -0.534 | -0.801 | [0.1 - 1] |
payoutRatioTTM | 0.826 | -1.000 | 1.740 | -1.740 | [0 - 1] |
currentRatioTTM | 1.411 | 0.800 | 7.94 | 6.36 | [1 - 3] |
quickRatioTTM | 0.789 | 0.800 | -0.0655 | -0.0524 | [0.8 - 2.5] |
cashRatioTTM | 0.327 | 1.500 | 9.30 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.333 | -1.500 | 4.46 | -6.69 | [0 - 0.6] |
interestCoverageTTM | -724.00 | 1.000 | -10.00 | -10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 12.99 | 2.00 | 5.67 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 10.45 | 2.00 | 4.77 | 9.55 | [0 - 20] |
debtEquityRatioTTM | 0.702 | -1.500 | 7.19 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.412 | 1.000 | 6.46 | 6.46 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.110 | 1.000 | 9.80 | 9.80 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.209 | 1.000 | 9.95 | 9.95 | [0.2 - 2] |
assetTurnoverTTM | 0.364 | 0.800 | -0.906 | -0.725 | [0.5 - 2] |
Total Score | 8.57 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 50.73 | 1.000 | 4.98 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0519 | 2.50 | -0.343 | -0.801 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 10.45 | 2.00 | 6.52 | 9.55 | [0 - 30] |
dividendYielPercentageTTM | 1.593 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 12.99 | 2.00 | 5.67 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.826 | 1.500 | 1.740 | -1.740 | [0 - 1] |
pegRatioTTM | 0.217 | 1.500 | -1.889 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.191 | 1.000 | 7.73 | 0 | [0.1 - 0.5] |
Total Score | 4.16 |
Becton Dickinson and Co
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej